 | • レポートコード：B-GIR08C4904 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、レゴラフェニブの世界市場について調べ、まとめました。種類別セグメントは、ボトル包装、フィルムコーティング包装等、用途別セグメントは、転移性大腸がん、進行性消化管間質性腫瘍、進行性肝細胞がん、その他等に区分しました。レゴラフェニブの世界市場概観、企業動向、企業別レゴラフェニブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・レゴラフェニブの市場概観 ・レゴラフェニブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・レゴラフェニブの企業別販売動向、市場シェア、市場集中度、競争動向 ・レゴラフェニブの世界市場規模 ・レゴラフェニブの北米市場分析（アメリカ、カナダ、メキシコ等） ・レゴラフェニブのアメリカ市場規模推移 ・レゴラフェニブのカナダ市場規模推移 ・レゴラフェニブのメキシコ市場規模推移 ・レゴラフェニブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・レゴラフェニブのドイツ市場規模推移 ・レゴラフェニブのイギリス市場規模推移 ・レゴラフェニブのロシア市場規模推移 ・レゴラフェニブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・レゴラフェニブの日本市場規模推移 ・レゴラフェニブの中国市場規模推移 ・レゴラフェニブの韓国市場規模推移 ・レゴラフェニブのインド市場規模推移 ・レゴラフェニブの東南アジア市場規模推移 ・レゴラフェニブの南米市場分析（ブラジル、アルゼンチン等） ・レゴラフェニブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・レゴラフェニブの種類別分析/販売量、売上、市場シェア（ボトル包装、フィルムコーティング包装） ・レゴラフェニブの用途別分析/市場規模（転移性大腸がん、進行性消化管間質性腫瘍、進行性肝細胞がん、その他） ・レゴラフェニブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・レゴラフェニブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Regorafenib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Regorafenib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer Pharmaceuticals
Beacon Pharmaceuticals
Drug International
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Bottled Packaging
Film Coated Packaging
Market Segment by Applications, can be divided into
Metastatic Colorectal Cancer
Advanced Gastrointestinal Stromal Tumours
Advanced Hepatocellular Carcinoma
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Regorafenib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Regorafenib, with price, sales, revenue and global market share of Regorafenib in 2017 and 2018.
Chapter 3, the Regorafenib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Regorafenib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Regorafenib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Regorafenib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Regorafenib Introduction
1.2 Market Analysis by Type
1.2.1 Bottled Packaging
1.2.2 Film Coated Packaging
1.3 Market Analysis by Applications
1.3.1 Metastatic Colorectal Cancer
1.3.2 Advanced Gastrointestinal Stromal Tumours
1.3.3 Advanced Hepatocellular Carcinoma
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer Pharmaceuticals
2.1.1 Business Overview
2.1.2 Regorafenib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Pharmaceuticals Regorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Beacon Pharmaceuticals
2.2.1 Business Overview
2.2.2 Regorafenib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Beacon Pharmaceuticals Regorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Drug International
2.3.1 Business Overview
2.3.2 Regorafenib Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Drug International Regorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Regorafenib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Regorafenib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Regorafenib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Regorafenib Manufacturer Market Share in 2018
3.3.2 Top 6 Regorafenib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Regorafenib Market Analysis by Regions
4.1 Global Regorafenib Sales, Revenue and Market Share by Regions
4.1.1 Global Regorafenib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Regorafenib Revenue and Market Share by Regions (2014-2019)
4.2 North America Regorafenib Sales and Growth Rate (2014-2019)
4.3 Europe Regorafenib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Regorafenib Sales and Growth Rate (2014-2019)
4.5 South America Regorafenib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Regorafenib Sales and Growth Rate (2014-2019)
5 North America Regorafenib by Country
5.1 North America Regorafenib Sales, Revenue and Market Share by Country
5.1.1 North America Regorafenib Sales and Market Share by Country (2014-2019)
5.1.2 North America Regorafenib Revenue and Market Share by Country (2014-2019)
5.2 United States Regorafenib Sales and Growth Rate (2014-2019)
5.3 Canada Regorafenib Sales and Growth Rate (2014-2019)
5.4 Mexico Regorafenib Sales and Growth Rate (2014-2019)
6 Europe Regorafenib by Country
6.1 Europe Regorafenib Sales, Revenue and Market Share by Country
6.1.1 Europe Regorafenib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Regorafenib Revenue and Market Share by Country (2014-2019)
6.2 Germany Regorafenib Sales and Growth Rate (2014-2019)
6.3 UK Regorafenib Sales and Growth Rate (2014-2019)
6.4 France Regorafenib Sales and Growth Rate (2014-2019)
6.5 Russia Regorafenib Sales and Growth Rate (2014-2019)
6.6 Italy Regorafenib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Regorafenib by Country
7.1 Asia-Pacific Regorafenib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Regorafenib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Regorafenib Revenue and Market Share by Country (2014-2019)
7.2 China Regorafenib Sales and Growth Rate (2014-2019)
7.3 Japan Regorafenib Sales and Growth Rate (2014-2019)
7.4 Korea Regorafenib Sales and Growth Rate (2014-2019)
7.5 India Regorafenib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Regorafenib Sales and Growth Rate (2014-2019)
8 South America Regorafenib by Country
8.1 South America Regorafenib Sales, Revenue and Market Share by Country
8.1.1 South America Regorafenib Sales and Market Share by Country (2014-2019)
8.1.2 South America Regorafenib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Regorafenib Sales and Growth Rate (2014-2019)
8.3 Argentina Regorafenib Sales and Growth Rate (2014-2019)
8.4 Colombia Regorafenib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Regorafenib by Countries
9.1 Middle East and Africa Regorafenib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Regorafenib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Regorafenib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Regorafenib Sales and Growth Rate (2014-2019)
9.3 Turkey Regorafenib Sales and Growth Rate (2014-2019)
9.4 Egypt Regorafenib Sales and Growth Rate (2014-2019)
9.5 Nigeria Regorafenib Sales and Growth Rate (2014-2019)
9.6 South Africa Regorafenib Sales and Growth Rate (2014-2019)
10 Global Regorafenib Market Segment by Type
10.1 Global Regorafenib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Regorafenib Sales and Market Share by Type (2014-2019)
10.1.2 Global Regorafenib Revenue and Market Share by Type (2014-2019)
10.2 Bottled Packaging Sales Growth and Price
10.2.1 Global Bottled Packaging Sales Growth (2014-2019)
10.2.2 Global Bottled Packaging Price (2014-2019)
10.3 Film Coated Packaging Sales Growth and Price
10.3.1 Global Film Coated Packaging Sales Growth (2014-2019)
10.3.2 Global Film Coated Packaging Price (2014-2019)
11 Global Regorafenib Market Segment by Application
11.1 Global Regorafenib Sales Market Share by Application (2014-2019)
11.2 Metastatic Colorectal Cancer Sales Growth (2014-2019)
11.3 Advanced Gastrointestinal Stromal Tumours Sales Growth (2014-2019)
11.4 Advanced Hepatocellular Carcinoma Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Regorafenib Market Forecast (2019-2024)
12.1 Global Regorafenib Sales, Revenue and Growth Rate (2019-2024)
12.2 Regorafenib Market Forecast by Regions (2019-2024)
12.2.1 North America Regorafenib Market Forecast (2019-2024)
12.2.2 Europe Regorafenib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Regorafenib Market Forecast (2019-2024)
12.2.4 South America Regorafenib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Regorafenib Market Forecast (2019-2024)
12.3 Regorafenib Market Forecast by Type (2019-2024)
12.3.1 Global Regorafenib Sales Forecast by Type (2019-2024)
12.3.2 Global Regorafenib Market Share Forecast by Type (2019-2024)
12.4 Regorafenib Market Forecast by Application (2019-2024)
12.4.1 Global Regorafenib Sales Forecast by Application (2019-2024)
12.4.2 Global Regorafenib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Regorafenib Picture
Table Product Specifications of Regorafenib
Figure Global Sales Market Share of Regorafenib by Types in 2018
Table Regorafenib Types for Major Manufacturers
Figure Bottled Packaging Picture
Figure Film Coated Packaging Picture
Figure Regorafenib Sales Market Share by Applications in 2018
Figure Metastatic Colorectal Cancer Picture
Figure Advanced Gastrointestinal Stromal Tumours Picture
Figure Advanced Hepatocellular Carcinoma Picture
Figure Other Picture
Figure United States Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure France Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure China Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure India Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Regorafenib Revenue (Value) and Growth Rate (2014-2024)
Table Bayer Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Bayer Pharmaceuticals Regorafenib Type and Applications
Table Bayer Pharmaceuticals Regorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Beacon Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Beacon Pharmaceuticals Regorafenib Type and Applications
Table Beacon Pharmaceuticals Regorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Drug International Basic Information, Manufacturing Base and Competitors
Table Drug International Regorafenib Type and Applications
Table Drug International Regorafenib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Regorafenib Sales by Manufacturer (2017-2018)
Figure Global Regorafenib Sales Market Share by Manufacturer in 2017
Figure Global Regorafenib Sales Market Share by Manufacturer in 2018
Table Global Regorafenib Revenue by Manufacturer (2017-2018)
Figure Global Regorafenib Revenue Market Share by Manufacturer in 2017
Figure Global Regorafenib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Regorafenib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Regorafenib Manufacturer (Revenue) Market Share in 2018
Figure Global Regorafenib Sales and Growth Rate (2014-2019)
Figure Global Regorafenib Revenue and Growth Rate (2014-2019)
Table Global Regorafenib Sales by Regions (2014-2019)
Table Global Regorafenib Sales Market Share by Regions (2014-2019)
Table Global Regorafenib Revenue by Regions (2014-2019)
Figure Global Regorafenib Revenue Market Share by Regions (2014-2019)
Figure Global Regorafenib Revenue Market Share by Regions in 2018
Figure North America Regorafenib Sales and Growth Rate (2014-2019)
Figure Europe Regorafenib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Regorafenib Sales and Growth Rate (2014-2019)
Figure South America Regorafenib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Regorafenib Sales and Growth Rate (2014-2019)
Figure North America Regorafenib Revenue and Growth Rate (2014-2019)
Table North America Regorafenib Sales by Countries (2014-2019)
Table North America Regorafenib Sales Market Share by Countries (2014-2019)
Figure North America Regorafenib Sales Market Share by Countries (2014-2019)
Figure North America Regorafenib Sales Market Share by Countries in 2018
Table North America Regorafenib Revenue by Countries (2014-2019)
Table North America Regorafenib Revenue Market Share by Countries (2014-2019)
Figure North America Regorafenib Revenue Market Share by Countries (2014-2019)
Figure North America Regorafenib Revenue Market Share by Countries in 2018
Figure United States Regorafenib Sales and Growth Rate (2014-2019)
Figure Canada Regorafenib Sales and Growth Rate (2014-2019)
Figure Mexico Regorafenib Sales and Growth Rate (2014-2019)
Figure Europe Regorafenib Revenue and Growth Rate (2014-2019)
Table Europe Regorafenib Sales by Countries (2014-2019)
Table Europe Regorafenib Sales Market Share by Countries (2014-2019)
Table Europe Regorafenib Revenue by Countries (2014-2019)
Figure Europe Regorafenib Revenue Market Share by Countries (2014-2019)
Figure Europe Regorafenib Revenue Market Share by Countries in 2018
Figure Germany Regorafenib Sales and Growth Rate (2014-2019)
Figure UK Regorafenib Sales and Growth Rate (2014-2019)
Figure France Regorafenib Sales and Growth Rate (2014-2019)
Figure Russia Regorafenib Sales and Growth Rate (2014-2019)
Figure Italy Regorafenib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Regorafenib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Regorafenib Sales by Countries (2014-2019)
Table Asia-Pacific Regorafenib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Regorafenib Sales Market Share by Countries 2018
Table Asia-Pacific Regorafenib Revenue by Countries (2014-2019)
Figure Asia-Pacific Regorafenib Revenue Market Share by Countries 2018
Figure China Regorafenib Sales and Growth Rate (2014-2019)
Figure Japan Regorafenib Sales and Growth Rate (2014-2019)
Figure Korea Regorafenib Sales and Growth Rate (2014-2019)
Figure India Regorafenib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Regorafenib Sales and Growth Rate (2014-2019)
Figure South America Regorafenib Revenue and Growth Rate (2014-2019)
Table South America Regorafenib Sales by Countries (2014-2019)
Table South America Regorafenib Sales Market Share by Countries (2014-2019)
Figure South America Regorafenib Sales Market Share by Countries in 2018
Table South America Regorafenib Revenue by Countries (2014-2019)
Table South America Regorafenib Revenue Market Share by Countries (2014-2019)
Figure South America Regorafenib Revenue Market Share by Countries in 2018
Figure Brazil Regorafenib Sales and Growth Rate (2014-2019)
Figure Argentina Regorafenib Sales and Growth Rate (2014-2019)
Figure Colombia Regorafenib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Regorafenib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Regorafenib Sales by Countries (2014-2019)
Table Middle East and Africa Regorafenib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Regorafenib Sales Market Share by Countries in 2018
Table Middle East and Africa Regorafenib Revenue by Countries (2014-2019)
Table Middle East and Africa Regorafenib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Regorafenib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Regorafenib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Regorafenib Sales and Growth Rate (2014-2019)
Figure UAE Regorafenib Sales and Growth Rate (2014-2019)
Figure Egypt Regorafenib Sales and Growth Rate (2014-2019)
Figure Nigeria Regorafenib Sales and Growth Rate (2014-2019)
Figure South Africa Regorafenib Sales and Growth Rate (2014-2019)
Table Global Regorafenib Sales by Type (2014-2019)
Table Global Regorafenib Sales Share by Type (2014-2019)
Table Global Regorafenib Revenue by Type (2014-2019)
Table Global Regorafenib Revenue Share by Type (2014-2019)
Figure Global Bottled Packaging Sales Growth (2014-2019)
Figure Global Bottled Packaging Price (2014-2019)
Figure Global Film Coated Packaging Sales Growth (2014-2019)
Figure Global Film Coated Packaging Price (2014-2019)
Table Global Regorafenib Sales by Application (2014-2019)
Table Global Regorafenib Sales Share by Application (2014-2019)
Figure Global Advanced Gastrointestinal Stromal Tumours Sales Growth (2014-2019)
Figure Global Advanced Hepatocellular Carcinoma Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Regorafenib Sales, Revenue and Growth Rate (2019-2024)
Table Global Regorafenib Sales Forecast by Regions (2019-2024)
Table Global Regorafenib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Regorafenib Market Forecast (2019-2024)
Figure Europe Sales Regorafenib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Regorafenib Market Forecast (2019-2024)
Figure South America Sales Regorafenib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Regorafenib Market Forecast (2019-2024)
Table Global Regorafenib Sales Forecast by Type (2019-2024)
Table Global Regorafenib Market Share Forecast by Type (2019-2024)
Table Global Regorafenib Sales Forecast by Application (2019-2024)
Table Global Regorafenib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の転移性大腸がんの治療市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…- 世界の転移性結腸直腸がん手術市場：市場規模・現状・予測 Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- ラムシルマブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Ramucirumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Ramucirumab in global marke…
- アパチニブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Apatinib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Apatinib in global market, esp…
- 世界の半導体アドバンストパッケージング市場2019 The global Semiconductor Advanced Packaging market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Semiconductor Advanced Packaging market status and forecast, categorizes the global Semiconductor …